2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2006 |


  1. Ondricek
    AJ, Kashyap AK, Thamake SI, Vishwanatha JK, A comparative study of
    phytoestrogen action in mitigating apoptosis induced by oxidative
    stress, In Vivo. 2012 Sep; 26(5):765-75.
  2. Amalendu
    P Ranjan, Anindita Mukerjee, Lawrence Helson and Jamboor K Vishwanatha,
    Scale up, Optimization and Stability Analysis of Curcumin C3
    complex-loaded Nanoparticles for Cancer Therapy,  2012, 10:38 doi:10.1186/1477-3155-10-38
  3. Praveenkumar
    K. Shetty, Sanjay I. Thamake, Swati Biswas, Sonny L. Johansson, Jamboor
    K. Vishwanatha, Reciprocal regulation of Annexin A2 and EGFR with Her-2
    in Her-2 negative and Herceptin-resistant breast cancer, PLOS ONE 7(9):
    e44299. doi:10.1371/journal.pone.0044299
  4. Thamake
    SI, Raut SL, Gryczynski Z, Ranjan AP, Vishwanatha JK., Alendronate
    coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active
    targeting of metastatic breast cancer. Biomaterials. 2012
    Oct;33(29):7164-73. Epub 2012 Jul 12.
  5. Mukerjee
    A, Ranjan AP, Vishwanatha JK., Combinatorial nanoparticles for cancer
    diagnosis and therapy. Curr Med Chem. 2012 Aug 1;19(22):3714-21.
  6. Fudala R, Rich
    R, Mukerjee A, Ranjan AP, Vishwanatha JK, Kurdowska AK, Gryczynski Z,
    Borejdo J, Gryczynski I., Fluorescence Detection of MMP-9.II.
    Ratiometric FRET-Based Sensing With Dually Labeled Specific Peptide.,
    Curr Pharm Biotechnol. 2012 Feb 20. [Epub ahead of print]
  7. Dasgupta S,
    Srinidhi S, Vishwanatha JK., Oncogenic activation in prostate cancer
    progression and metastasis: Molecular insights and future challenges, J
    Carcinog. 2012;11:4. Epub 2012 Feb 17.

back to top


  1. Valapala, M.
    and Vishwanatha, J.K.  Lipid raft endocytosis and exosomal transport
    facilitate extracellular trafficking of annexin A2.  J. Biol. Chem. (Accepted for publication, July 7, 2011).
  2. Dasgupta, S.,
    Cushman, I., Kpetemey, M., Casey, P.J. and Vishwanatha, J.K. Prenylated
    C17ORF37 induces filopodia formation to promote cell migration and
    metastasis.  J. Biol. Chem. 2011 Jul 22;286(29):25935-46. Epub 2011 May 31.
  3. Ranjan, A. P.,
    Zeglam, K., Thamake, S.I., Mukerjee, A. and Vishwanatha, J.K. (2011) A
    sustained release formulation of chitosan modified PLCL: Poloxamer blend
    nanoparticles loaded with thermo-optical agent for animal imaging.  Nanotechnology 22(29):295104. Epub 2011 Jun 21. PMID: 1693801.
  4. Chiu, S.S.,
    Lui, E., Majeed, M., Vishwanatha, J.K., Ranjan, A.P., Maitra, A.,
    Pramanik, D., Smith, J.A. and Helson, L. (2011)  Differential
    distribution of intravenous curcumin formulations in the rat brain.
    Anticancer Res. 31(3): 907-911.  PMID: 21498712.
  5. Cardarelli KM,
    Jackson RS, Martin M, Linnear K, Lopez R, Senteio C, Weaver P, Hill A,
    Epperson-Brown M, Parish D, Newton JR, Haley S, Vishwanatha JK, Johnson
    E. (2011) Community-based participatory approach to reduce breast cancer
    disparities in South Dallas.  Progress in Community Health Partnerships (Accepted for publication, March 28th, 2011)
  6. Zhang, F.-F.,
    Morabia, A., Carroll, J., Gonzalez, K., Fulda, K., Kaur, M.,
    Vishwanatha, J.K., Santella, R.M. and Cardarelli, R. (2011) Dietary
    patterns and global genomic DNA methylation in a cancer-free
    population.  J. Nutr. published 27 April 2011, 10.3945/jn.110.134536. PMID: 21525250.
  7. Valapala, M.,
    Thamake, S.I. and Vishwanatha, J.K. (2011) A competitive hexapeptide
    inhibitor of Annexin A2 prevents hypoxia-induced angiogenic events.  J. Cell Sci. 124: 1453-1464. PMID: 21486955
  8. Thamake, S.I.,
    Raut, S.L., Ranjan, A.P., Gryczynski, Z. and Vishwanatha, J.K. (2011)
    Surface functionalization of PLGA nanoparticles by non-covalent
    insertion of a homo-bifunctional spacer for active targeting in cancer
    therapy.  Nanotechnology 22(3):035101. Epub 2010 Dec 9. PMID: 21149963.
  9. Fudala, R., Ranjan, A.P., Mukerjee, A., Vishwanatha, J.K., Gryczynski, Z., Borejdo, J., Sarkar, P.
    and  Gryczynski, I. (2011)  Fluorescence Detection of MMP-9. I. MMP-9
    Selectively Cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys Peptide.  Curr. Pharm. Biotechnol. 12:834-838. PMID: 21446907.
  10. Raut, S.,
    Heck, A., Vishwanatha, J.K., Sarkar, P., Mody, A., Luchowski, R.,
    Gryczysnki, Z., and Gryczynski, I. (2011) Fluorescent Properties of
    Antioxidant Cysteine ABZ Analogue.  J. Photochem. Photobiol. B. Biology 102: 241-245. PMID: 21237671
  11. Zhang, F.-F.,
    Cardarelli, R., Carroll, J., Zhang, S., Fulda, K., Gonzalez, K.,
    Vishwanatha, J.K., Morabia, A. and Santella, R.M. (2011)  Physical
    activity and global genomic DNA methylation in a cancer-free
    population.  Epigenetics 6(3):293-9.PMID: 21178401
  12. Nejtek, V.A.,
    Kaiser, K., Vo, H., Hilburn, C. Lea, J., and Vishwanatha, J.K. (2011)
    Are there racial/ethnic differences in indigent inner-city clients with
    dual diagnoses?  J. Dual Diagnosis 7(1-2): 26-38.\

back to top


  1. Shankardas,
    J., Patil, R. V. and Vishwanatha, J.K. (2010) Effect of down-regulation
    of aquaporins in human corneal endothelial and epithelial cell lines.  Mol. Vision 16:1538-1548.  PMID: 20806077 PMCID: PMC2925904
  2. Mukerjee,
    A., Sørensen, T.J., Ranjan, A.P., Raut, S., Gryczynski, I., Vishwanatha,
    J.K. and Gryczynski, Z.  (2010) Spectroscopic Properties of Curcumin:
    Orientation of Transition MomentsJ Phys Chem B. 114(39):12679-84. PMID: 20839868
  3. Das, S.,
    Shetty, P., Valapala, M., Dasgupta, S., Gryczynski, Z. and Vishwanatha,
    J.K. (2010) Signal transducer and activator of transcription 6 (STAT6)
    is a novel interactor of annexin A2 in prostate cancer cells.  Biochemistry,49 (10):2216–2226.  PMID: 20121258.
  4. Cardarelli,
    R., Cardarelli, K.M., Carroll, J., Fulda, K.G., Espinoza, A., Cage, C.,
    Vishwanatha, J.K., Young, R. and Steele, D. N. (2010) Perceived racial
    discrimination, response to unfair treatment, and coronary calcification
    in asymptomatic adults – the North Texas Healthy Heart Study.  BMC
    Public Health, 10:285. PMID: 20507602
  5. Mukerjee, A.,
    Luchowski, R., Ranjan, A.P., Raut, S., Vishwanatha, J.K., Gryczynski, Z.
    and Gryczynski, I. (2010) Enhanced fluorescence of curcumin on
    plasmonic platforms.  Curr. Phar. Biotech. 11(2):223-228. PMID: 20210735
  6. Deshmukh,
    A., Kim, B.-J., Gonzales, X., Caffrey, J., Vishwanatha, J.K. and Jones,
    H.P. (2010) A murine model of stress-controllability and stress-induced
    allergic airway hypersensitivity.  J. Neuroimmunol. J. Neuroimmunol. 225:13-21. PMID: 20462642.

back to top


  1. Dasgupta, S., Wasson, L.M., Rauniyar, N., Prokai, L., Borejdo, J.
    and Vishwanatha, J.K. (2009) Novel gene C17orf37 in 17q12 amplicon
    promotes migration and invasion of prostate cancer cells.  Oncogene 28(32):2860-72. PMID: 19503095.
  2. Mukerjee, A., and Vishwanatha, J.K. (2009)  Formulation,
    characterization and evaluation of curcumin loaded PLGA nanospheres for
    cancer therapy.  Anticancer Res. 29(10):3867-3875. PMID: 19846921.
  3. Carroll, J.F., Fulda, K.G., Chiapa, A.L., Rodriguez, M., Phelps,
    D.R., Cardarelli, K.M., Vishwanatha, J.K., Cardarelli, R. (2009) Impact
    of race/ethnicity on the relationship between visceral fat and
    inflammatory biomarkers. Obesity 17(7):1420-1427. PMID: 19197255.
  4. Braden,A. R., Kafka, M.T., Cunningham, L., Jones, H. and
    Vishwanatha, J.K. (2009) Polymeric nanoparticles for sustained
    down-regulation of annexin A2 inhibit prostate tumor growth.  J. Nanosci. Nanotech. 9(5):2856-2865. PMID: 19452941.


  1. Reeves, R.E., Vishwanatha, J.K., Yorio, T., Budd, M., Sheedlo, H.J. (2008) The Post-baccalaureate Premedical Certification Program at the University of North Texas Health Science Center Strengthens Admission Qualifications for Entrance into Medical School. Academic Medicine, 83(1):45-51. PMID: 18162749.
  2. Bhutia, S.K., Mallick, S.K., Stanley, S.M., Prokai, L, Vishwanatha,
    J.K. and Maiti, T.K. (2008) Induction of mitochondria-dependent
    apoptosis by Abrus agglutinin-derived peptides in human cervical cancer cell.  Toxicol. In vitro 22(2):344-351.
  3. Carroll J.F., Chiapa A.L., Rodriguez M., Phelps D.R., Cardarelli
    K.M., Vishwanatha J.K., Bae S., Cardarelli R. (2008) Visceral fat, waist
    circumference and body mass index: Impact of race/ethnicity. Obesity16(3):600-607.
  4. Kafka, E.L., Braden, A. and Vishwanatha, J.K. (2008)
    Characterization of nanoparticle-mediated drug delivery to NB4:
    feasibility of nanoparticle use for cells in suspension and blood
    diseases.  J. Biomed. Nanotechnol. 4, 196–202. PMID: 19452941

back to top


  1. Braden, A., Kashyap, A., Vasir, J., Labhasetwar, V. and Vishwanatha,
    J.K. (2007) Polymeric nanoparticles for sustained down-regulation of
    Annexin A2 lead to reduction in proliferation and migration of prostate
    cancer cells.  J. Biomed. Nanotech. 3(2):148-159.
  2. Das, S., Roth, C.P., Wasson, L.M. and Vishwanatha, J.K. (2007)
    Signal transducer and activator of transcription-6 (STAT6) is a
    constitutively expressed survival factor in human prostate cancer.  Prostate 67:1550-1564.
  3. Liu, J. and Vishwanatha, J.K. (2007) Regulation of nucleo-cytoplasmic shuttling of human annexin II – A proposed mechanism.  Mol. Cell. Biochem. 303:211-220.|
  4. Banerjee, A. G., Gopalakrishnan, V.K. and Vishwanatha, J.K. (2007)
    Nicotine Inhibits Nitric Oxide-induced Apoptosis in Oral Epithelial
    Cells. Mol. Cell. Biochem. 305(1-2):113-21.

back to top


  1. Banerjee, A.G., Bhattacharyya, I. and Vishwanatha, J.K. (2005)
    Identification of genes and molecular pathways involved in the
    progression of premalignant oral epithelia.  Mol. Cancer Therap. 4(6): 865-875.
  2. Rothermund, C.A., Gopalakrishnan, V.K., Eudy, J.D. and Vishwanatha,
    J.K. (2005) Casodex treatment induces hypoxia-related gene expression in
    the LNCaP prostate cancer progression model.  BMC Urology 5: 5.